Response evaluation: beyond RECIST

Ann Oncol. 2007 Jul:18 Suppl 9:ix29-32. doi: 10.1093/annonc/mdm290.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials, Phase II as Topic*
  • Clinical Trials, Phase III as Topic*
  • Disease-Free Survival
  • Humans
  • Neoplasms / diagnostic imaging
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • Practice Guidelines as Topic / standards
  • Radiography
  • Randomized Controlled Trials as Topic*

Substances

  • Antineoplastic Agents